Crinetics Pharmaceuticals, Inc. (CRNX) Social Stream
CRINETICS PHARMACEUTICALS INC (CRNX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering CRINETICS PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 5 | $42 | $35 | $37.25 | $16.85 | 121.07% |
| 2021-11-23 | 6 | $68 | $35 | $43.4 | $16.85 | 157.57% |
| 2022-02-02 | 5 | $68 | $35 | $43.333 | $16.85 | 157.17% |
| 2022-05-16 | 6 | $68 | $35 | $43.833 | $16.85 | 160.14% |
| 2022-05-26 | 6 | $68 | $35 | $44.333 | $16.85 | 163.1% |
| 2022-08-15 | 6 | $68 | $35 | $44.5 | $16.85 | 164.09% |
| 2022-11-18 | 6 | $44 | $35 | $39.4 | $16.85 | 133.83% |
| 2023-01-13 | 4 | $44 | $35 | $38.5 | $16.85 | 128.49% |
| 2023-03-01 | 6 | $44 | $35 | $38.5 | $16.85 | 128.49% |
| 2023-03-10 | 6 | $44 | $35 | $38.8 | $16.85 | 130.27% |
The Trend in the Analyst Price Target
Over the past 19 months, CRNX's average price target has gone up $1.3.
CRNX reports an average of 118.69% for its upside potential over the past 49 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-04-21 | 6 | 68 | 35 | 43.833 | 21.16 | 107.15% |
| 2022-09-07 | 6 | 68 | 35 | 44.166 | 21.62 | 104.28% |
| 2022-11-18 | 4 | 44 | 35 | 38.500 | 17.83 | 115.93% |
| 2023-03-01 | 6 | 44 | 35 | 38.800 | 19.64 | 97.56% |
| 2023-03-10 | 6 | 44 | 35 | 38.800 | 17.28 | 124.54% |
CRNX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 6 | 0 | 0 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
Over the past 48 weeks, CRNX's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- CRNX has a lower variance in analysts' estimates than -707.81% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, CRINETICS PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 1332.03% of them.
- In terms of how CRINETICS PHARMACEUTICALS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 446.46% of that group.
- CRNX has a higher average analyst price target than 1432.89% of stocks in the small market cap category.
Stocks similar to CRINETICS PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are MGTA, APTX, and KZR.
View All Top Stocks by Price Target
Make investment decisions regarding CRNX using the data that counts. Try POWR Ratings for free.